Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Nov;10(6):431-442.
doi: 10.1111/cts.12488. Epub 2017 Aug 3.

The Role of Public-Private Partnerships in Catalyzing the Critical Path

Kimberly E Maxfield  1 , ShaAvhrée Buckman-Garner  2 , Ameeta Parekh  2
Affiliations
Review

The Role of Public-Private Partnerships in Catalyzing the Critical Path

Kimberly E Maxfield et al. Clin Transl Sci. 2017 Nov.
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Therapeutic areas and needs addressed by PPPs: Ongoing and completed initiatives and deliverables (2006‐July 2016). Heat map of identified PPP initiatives and deliverables from publicly available sources arranged by therapeutic need areas.
Figure 2
Figure 2
Critical path opportunities addressed by PPPs: ongoing and completed initiatives and deliverables by CPOL topics. Bar graph of the number of ongoing and completed PPP initiatives and deliverables identified in Figure 1 that address one of the six CPOL topics. Inset: Percentage of ongoing and completed PPP initiatives and deliverables per CPOL opportunity topic.
See this image and copyright information in PMC

References

    1. US Food and Drug Administration . Innovation or Stagnation: Challenge and Opportunity on the Critical Path to New Medical Products. http://www.fda.gov/downloads/ScienceResearch/SpecialTopics/CriticalPathI... 2017, June 9.
    1. US Food and Drug Administration . Critical Path Opportunities List. http://www.fda.gov/downloads/ScienceResearch/SpecialTopics/CriticalPathI... 2017, June 9.
    1. Parekh, A. et al Catalyzing the Critical Path Initiative: FDA's progress in drug development activities. Clin. Pharmacol. Ther. 97, 221–233 (2015). - PubMed
    1. US Food and Drug Administration . CDER Staff Participation in Public Private Partnerships and Consortia. https://www.fda.gov/downloads/AboutFDA/CentersOffices/OfficeofMedicalPro... 2017, March 1.
    1. Goodsaid, F.M. & Mendrick, D.L. Translational medicine and the value of biomarker qualification. Sci. Transl. Med. 2, 47ps4 (2010). - PubMed

LinkOut - more resources